What is meant by Slightly expanded potential trial DTC program?
If you're referring to the "pilot" program HDG, BB and others were discussing, where some suggested DTC ads using 1A win to promote off-label use, I have a different idea - instead of AMRN fighting with FDA on what they can or can't promote (IIRC FDA has to approve any new 1A promotions based on peer reviewed publications, how about this: Give patients with DES a free one month scrip, or allow them to use a special new coupon, to try V out and see if it works - those of use who had our DES go away know it happens in weeks, not months - then those patients can try to lobby insurers for coverage, perhaps with the help of AMRN, because V is much cheaper (plus more effective) than any other FDA approved DES therapy out there - insurers will save money, patients won't need painful injections done in a doctor's office (which also adds costs). Might be a hairbrained idea, could have the wrong off-label indication, but the gist of it is valid - I know there have been other drugs where bios offered free or greatly reduced prices for drugs which have multiple indications - my doc even gave me one of them a couple years ago, but it upset my GI system, so I quit trying it.
News 
Market Data 
Discover 
AI
